EICHORPublic-registry site landscape for NCT03531684, “Efficacy and Safety of MMFS in Early AD”, a Alzheimer Disease study sponsored by Neurocentria, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03531684 (registry record) |
| Study title | Efficacy and Safety of MMFS in Early AD |
| Official title | Clinical Trial to Test the Efficacy and Safety of MMFS-205 in Early Alzheimer's Disease Patients |
| Sponsor | Neurocentria, Inc. |
| Condition(s) | Alzheimer Disease |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT03531684.
Eichor generates a preliminary site-risk snapshot for NCT03531684 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Alzheimer Disease trials
← Eichor home · All tracked trials · Alzheimer Disease studies · Weekly briefs
